Free Trial

Fresenius SE & Co. (OTCMKTS:FSNUY) Releases Earnings Results, Misses Expectations By $0.01 EPS

Fresenius SE & Co. logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Q1 EPS missed estimates: Fresenius reported $0.24 EPS for the quarter, missing analysts' consensus of $0.25 by $0.01.
  • Shares and valuation: FSNUY traded at $11.91 midday—well below its 52‑week high of $33.93—with a market cap of $26.83 billion, a P/E of 18.91, and daily volume roughly half its average.
  • Analyst sentiment: Analysts remain positive—Citigroup and Morgan Stanley reaffirmed Buy/Overweight ratings, and the stock's average rating on MarketBeat is "Buy".
  • MarketBeat previews top five stocks to own in June.

Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report) posted its earnings results on Wednesday. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.25 by ($0.01), Zacks reports. Fresenius SE & Co. had a return on equity of 10.31% and a net margin of 5.71%.

Fresenius SE & Co. Price Performance

FSNUY stock traded up $0.30 during mid-day trading on Wednesday, hitting $11.91. The stock had a trading volume of 70,514 shares, compared to its average volume of 142,768. The company has a current ratio of 1.32, a quick ratio of 1.00 and a debt-to-equity ratio of 0.47. Fresenius SE & Co. has a 52 week low of $11.28 and a 52 week high of $33.93. The firm has a market capitalization of $26.83 billion, a P/E ratio of 18.91 and a beta of 0.68. The firm has a fifty day simple moving average of $13.13 and a 200 day simple moving average of $14.16.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on FSNUY. Citigroup reaffirmed a "buy" rating on shares of Fresenius SE & Co. in a research report on Tuesday, February 3rd. Morgan Stanley reaffirmed an "overweight" rating on shares of Fresenius SE & Co. in a research report on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of "Buy".

Check Out Our Latest Stock Analysis on Fresenius SE & Co.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world's leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.

Featured Stories

Earnings History for Fresenius SE & Co. (OTCMKTS:FSNUY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Fresenius SE & Co. Right Now?

Before you consider Fresenius SE & Co., you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius SE & Co. wasn't on the list.

While Fresenius SE & Co. currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines